About Kamau Therapeutics
Kamau Therapeutics is a private company based in South San Francisco, California, incorporated in 2023 in Delaware. It has reported $4,999,997 raised in one offering on Form D since June 2025. Its chief executive is Valentin Barsan.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 19, 2025 | Jun 3, 2025 | $4,999,997of $10.0M target | 6 | $833K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Kamau Therapeutics's Form D filed Jun 3, 2025.
RK
Raymond Kelleher
Director
MP
Matthew Porteus
Executive officer and director
VB
Valentin Barsan
Chief Executive Officer and director
NB
Ness Bermingham
Director